Wunderlich Capital Managemnt Becton Dickinson & CO Transaction History

Wunderlich Capital Managemnt

$212 Million
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $67,000 - $71,098	-287 Reduced 4.5%	6,094 $1.51 Million
Q4 2023 Feb 15, 2024	BUY	$232.24 - $267.23 $1.17 Million - $1.35 Million	5,040 Added 375.84%	6,381 $1.56 Million
Q3 2023 Nov 15, 2023	BUY	$254.9 - $283.59 $253,370 - $281,888	994 Added 286.46%	1,341 $346,000
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $228,135 - $253,813	-895 Reduced 72.06%	347 $347,000
Q2 2023 Aug 08, 2023	BUY	$238.39 - $265.32 $31,229 - $34,756	131 Added 11.79%	1,242 $328,000
Q1 2023 May 09, 2023	BUY	$229.71 - $259.35 $255,207 - $288,137	1,111 New	1,111 $275,000
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $1.46 Million - $1.61 Million	-6,271 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $221 - $245	-1 Reduced 0.02%	6,271 $1.57 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $50,058 - $64,208	232 Added 3.84%	6,272 $1.46 Million
Q2 2020 Aug 17, 2020	BUY	$219.9 - $263.41 $14,733 - $17,648	67 Added 1.12%	6,040 $1.45 Million
Q1 2020 May 14, 2020	SELL	$195.69 - $279.01 $36,006 - $51,337	-184 Reduced 2.99%	5,973 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $709 - $800	-3 Reduced 0.05%	6,157 $1.68 Million
Q3 2019 Nov 15, 2019	BUY	$230.58 - $256.08 $8,070 - $8,962	35 Added 0.57%	6,160 $1.56 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $751,769 - $850,944	3,458 Added 129.66%	6,125 $1.54 Million
Q1 2019 May 16, 2019	BUY	$206.05 - $248.17 $44,094 - $53,108	214 Added 8.72%	2,667 $666,000
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $502,202 - $632,702	2,453 New	2,453 $553,000

Others Institutions Holding BDX

# of Institutions

1,734

Shares Held

252M

Call Options Held

586K

Put Options Held

649K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

News

Stay updated on Wunderlich Capital Managemnt with notifications on news.

Account